• 71, SS21/37, Damansara Utama, 47400, Petaling Jaya, Selangor
  •           
  • +60 17-3613 715

Malaya Optical Attends Myopine Myopia Education Training

Malaya Optical attends Myopine educational training to learn about low-dose atropine research and childhood myopia management. Training only; no medication service.


Malaya Optical Expands Myopia Management Knowledge Through Myopine Educational Training

Continuing professional education helps our optometrists stay informed about developments in childhood myopia management, including low-dose atropine research.

Continuing Our Commitment to Professional Learning

At Malaya Optical, we believe that providing professional eye care begins with continuous learning.

As an optometry practice established in 1957, we have witnessed significant developments in spectacle lens technology, contact lenses, eye examination equipment and approaches to managing childhood myopia.

Today, myopia management is an increasingly important area of eye care, particularly as more parents seek to understand why their children’s spectacle prescriptions continue to change.

To broaden our professional knowledge, our team recently participated in educational training covering Myopine, a brand of low-dose atropine eye drops associated with childhood myopia management.

The session provided an opportunity to learn more about medication-based approaches discussed in myopia research, understand their clinical background and appreciate the different roles of eye care professionals.

This was an educational training session only. Malaya Optical does not prescribe, dispense, sell or administer Myopine or other atropine eye drops.

Understanding Myopine and Low-Dose Atropine

Myopine is a brand of eye drops containing atropine sulphate.

Low-dose atropine has been investigated in clinical studies as a potential approach to slowing myopia progression in children.

Unlike conventional spectacles, which correct blurred vision, atropine-based myopia management is intended to influence the rate at which myopia progresses.

Research has explored different concentrations of atropine, including 0.01% and 0.025%, with studies examining changes in refractive error, axial length and treatment tolerability.

However, atropine is a medication and is not suitable for every child.

Its use involves medical considerations, including potential side effects, contraindications and the need for appropriate clinical supervision.

Learning about these developments helps our team understand the broader field of childhood myopia management.

It does not mean that our optometrists are authorised to prescribe or provide atropine treatment.

Why Our Team Attended Myopine Training

Myopia management continues to evolve as researchers investigate different ways to address progressive short-sightedness.

While Malaya Optical focuses on optometric assessments and appropriate optical solutions, we believe it is valuable to understand developments taking place across the wider eye care profession.

The Myopine educational session allowed our team to explore several important topics.

Understanding the Science Behind Atropine

The session contributed to our understanding of how atropine is being studied in childhood myopia management.

Research has examined its potential effects on myopia progression and axial elongation, although treatment responses vary between individuals and concentrations.

Understanding the published evidence helps our optometrists remain informed about developments beyond spectacle and contact lens technologies.

Appreciating the Importance of Eye Growth Monitoring

Myopia management involves more than tracking changes in spectacle prescriptions.

Axial length, which measures the length of the eye, provides valuable information about eye growth.

This is particularly relevant when discussing childhood myopia because progressive axial elongation is associated with increasing myopia.

At Malaya Optical, our approach to myopia assessment includes evaluating prescription changes, ocular health and axial length where appropriate.

Our ARK Biometer Combo supports axial length measurement, allowing our optometrists to monitor changes over time.

We measure eye growth, not just prescription power.

Understanding Different Approaches to Myopia Management

There is no single approach that is suitable for every child.

Modern myopia management includes different optical technologies, such as specially designed spectacle lenses, orthokeratology and soft myopia management contact lenses.

Medication-based approaches, including atropine, form another area of clinical research and medical practice.

By learning about these different approaches, our team gains a broader understanding of the considerations involved in childhood myopia management.

This knowledge supports professional awareness and informed discussions about the importance of appropriate eye care.

It does not extend our scope of practice into medical prescribing.

Understanding Professional Roles in Myopia Management

Different eye care professionals have different responsibilities, qualifications and legal scopes of practice.

In Malaysia, optometrists practise within the applicable professional and regulatory framework.

Atropine eye drops are medicinal products, and decisions about their prescription and medical use must be made by appropriately authorised medical practitioners.

At Malaya Optical, we respect these professional boundaries.

Our participation in Myopine training was intended to improve our understanding of the subject, not to introduce a medication-based treatment service.

Malaya Optical does not provide prescriptions for Myopine, dispense the medication, sell atropine eye drops or administer atropine treatment.

Parents who wish to explore medication-based myopia management should consult an appropriately qualified medical practitioner, such as an ophthalmologist.

How This Knowledge Relates to Our Existing Myopia Assessments

Although Malaya Optical does not provide atropine treatment, understanding developments in myopia research remains relevant to our work as optometrists.

Children with progressive myopia benefit from regular eye examinations and appropriate monitoring.

Our optometric assessments may include:

  • Measuring visual acuity and refractive error.
  • Reviewing previous spectacle prescriptions.
  • Measuring axial length where appropriate.
  • Evaluating ocular health.
  • Discussing suitable optical myopia management options within our scope of practice.
  • Monitoring changes during follow-up examinations.

These assessments help parents understand how their child’s vision and eye growth are changing.

Where medical treatment is being considered, families should seek advice from an appropriately authorised medical practitioner.

Learning Beyond the Examination Room

Professional development is an important part of Malaya Optical’s approach to eye care.

Our team regularly seeks opportunities to learn about optical technologies, clinical research and developments relevant to our profession.

Educational sessions such as Myopine training allow us to remain informed about subjects that may arise during conversations with parents.

They also reinforce the importance of understanding the distinction between optical myopia management and medical treatment.

For us, professional learning is not simply about introducing new products or services.

It is also about developing knowledge, recognising professional responsibilities and understanding the wider context of eye care.

A Message to Parents: Knowledge Does Not Mean Treatment Availability

We understand that parents may be interested in different approaches to managing their child’s myopia.

For clarity, our participation in Myopine training should not be interpreted as an announcement that atropine treatment is available at Malaya Optical.

The session was educational in nature.

We are not launching a Myopine service, and we do not prescribe, dispense, sell or administer atropine eye drops.

Our role remains focused on optometric eye examinations, appropriate optical myopia management and monitoring within our professional scope.

Families considering atropine should seek medical advice from an appropriately authorised practitioner.

Continuing to Learn, Continuing to Grow

Since 1957, Malaya Optical has continued to develop its professional knowledge as the optical industry evolves.

Our recent Myopine educational training represents another opportunity for our team to learn about developments in childhood myopia research.

We appreciate the opportunity to expand our understanding of low-dose atropine and its place within the wider discussion of myopia management.

While this training does not change the services we provide or our professional scope of practice, it reflects our commitment to staying informed and maintaining responsible standards of optometric care.

At Malaya Optical, learning never stops — because understanding more helps us approach eye care with greater knowledge, awareness and responsibility.

Book an appointment here.


Important clarification: This article reports on a professional educational activity only. Malaya Optical does not prescribe, dispense, sell or administer Myopine or other atropine eye drops. Participation in the training does not confer prescribing authority, constitute medical certification or indicate that medication-based myopia treatment is available or planned at Malaya Optical. Parents seeking advice about atropine treatment should consult an appropriately authorised medical practitioner.

Accessibility Toolbar